Papile · Pediatria
Papile grading of germinal matrix and intraventricular hemorrhage
vigenteGrades germinal matrix and intraventricular hemorrhage in neonates.
Índice de referência, não é suporte à decisão clínica. O RadCommons apresenta conteúdo de referência reescrito a partir de critérios publicados e com link para a fonte primária. Confira sempre a publicação primária vigente. Não é um dispositivo médico nem substitui o julgamento clínico. O radiologista responsável pelo laudo permanece o autor e o responsável.
Escala de categorias
As figuras e tabelas estão na fonte primária. Abrir a fonte. O RadCommons reescreve e cita, não reproduz figuras protegidas por direitos autorais.
Procedência e vigência
- Órgão emissor
- Neonatal imaging consensus
- Versão
- 1978
- Ano
- 1978
- Família
- léxico
- Tipo de lógica
- flat
- Modalidade
- US
- Fonte primária
- Incidence and evolution of subependymal and intraventricular hemorrhage (Papile) · doi:10.1016/s0022-3476(78)80282-0
- Última verificação
- 2026-06-26
- Última checagem
- 2026-06-26
Lógica de decisão
Forma estruturada (flat). Uma futura calculadora a lê; as categorias abaixo são a superfície legível.
Mostrar a lógica estruturada (JSON)
{
"categories": [
"I",
"II",
"III",
"IV"
]
}Categorias num relance
| Cat. | Significado | Conduta | Risco | Fonte |
|---|---|---|---|---|
| I | Grade I Hemorrhage limited to the germinal matrix (subependymal), without extension into the ventricle. | Supportive neonatal care; serial cranial ultrasound surveillance is advised (roughly weekly for about four weeks and again at discharge) with head-circumference monitoring; no CSF diversion needed in the absence of ventricular dilatation. | Low-grade injury but not benign: cerebral palsy reported in roughly 7-8% at 2 years corrected age, and neurodevelopmental delay, hearing loss and CP can still occur. | okfonte Criteria: StatPearls NBK538310, Introduction. Management/risk: Inan/Karadag review (PMC7536465) — CP ~6.8% in grade I, weekly US surveillance for grades I-II. |
| II | Grade II Intraventricular hemorrhage occupying less than 50% of the ventricular area, without ventricular dilatation. | Supportive care with serial cranial ultrasound (about weekly for four weeks and at discharge) and head-circumference tracking; intervention reserved for any progressive ventricular dilatation. | Cerebral palsy reported in about 8% at 2 years, rising to ~12% when accompanied by ventricular dilatation or cystic/echodense periventricular leukomalacia. | okfonte Criteria: StatPearls NBK538310, Introduction. Management/risk: PMC7536465 — CP ~8.1% (12.2% with ventricular dilatation/PVL); weekly US surveillance for grades I-II. |
| III | Grade III Intraventricular hemorrhage with ventricular dilatation, the blood occupying more than 50% of the ventricle. | Closer cranial ultrasound surveillance (about twice weekly until discharge); for progressive post-hemorrhagic ventricular dilatation, temporizing CSF measures (ventricular reservoir or ventriculosubgaleal shunt) precede permanent ventriculoperitoneal shunting once the infant reaches ~2-2.5 kg. | Severe (grade III/IV) IVH: post-hemorrhagic hydrocephalus develops in roughly a third of very-low-birth-weight infants with IVH; cerebral palsy exceeds 50% and ~75% need special education in grade III-IV. | okfonte Criteria: StatPearls NBK538310, Introduction. Management/risk: PMC7536465 — twice-weekly US, reservoir/subgaleal shunt then VP shunt; PHH in ~1/3, CP >50% and special education ~75% in grade III-IV. |
| IV | Grade IV Intraventricular hemorrhage accompanied by intraparenchymal (periventricular) hemorrhage; previously termed Grade IV, now also called periventricular hemorrhagic infarction (PVHI). | Intensive cranial ultrasound surveillance (about twice weekly until discharge); progressive PHVD managed with temporizing CSF drainage (reservoir/ventriculosubgaleal shunt) and later permanent VP shunting; supportive care with seizure management. | Worst prognosis: roughly 30-40% die; severe neurodevelopmental disorder in ~55% (rising to ~86% with PVHI plus shunt); reported cerebral palsy ~60%, cognitive problems ~50%, visual field defects ~25%, epilepsy ~20%. | okfonte Criteria: StatPearls NBK538310, Introduction. Management/risk: PMC7536465 — mortality ~30-40%, severe NDD ~55% (86% with PVHI+shunt), CP ~60%, cognitive ~50%, visual defects ~25%, epilepsy ~20%. |
Histórico de versões
Nenhum evento de versão registrado.
Quickstart da APIGET /api/v1/systems/papile-ivhaberto
curl -s "https://radcommons.laudos.ai/api/v1/systems/papile-ivh"Ver documentação completa